Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Biomarin Pharmaceut (BMRN)

82.71 -0.28 (-0.34%)

11-24 13:00

Open:

82.66

Pre. Close:

82.99

High:

83.91

Low:

82.65

Volume:

243,750

Market Cap:

14526M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

84.15 - 85.19

85.19 - 86.07

Low:

80.77 - 81.51

81.51 - 82.13

Close:

81.73 - 83.16

83.16 - 84.36

Technical analysis  (as of: 2017-11-24 1:53:29 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 100.01     One year: 103.65

Support:

Support1: 80.58    Support2: 67.04

Resistance:

Resistance1: 85.62    Resistance2: 88.74

Pivot:

82.63

Moving Averages:

MA(5): 82.89     MA(20): 82.51

MA(100): 87.71     MA(250): 88.53

MACD:

MACD(12,26): -1.36     Signal(12,26,9): -1.77

%K %D:

%K(14,3): 62.23     %D(3): 63.35

RSI:

RSI(14): 40.51

52-Week:

High: 100.51  Low: 79.5  Change(%): -6.4

Average Vol(K):

3-Month: 166722  10-Days 88953

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
BMRN has closed below upper band by 47.3%. Bollinger Bands are 63.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to BMRN's normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 20 Nov 2017 16:52:30 GMT
BioMarin Pharmaceutical: Appeal Improves, Not A Buyer Yet

Wed, 01 Nov 2017 20:37:30 GMT
BioMarin Pharmaceutical Inc. on Target for Its 15% Revenue Growth Goal

Fri, 27 Oct 2017 02:22:32 GMT
BioMarin Pharmaceutical (BMRN) Q3 2017 Results - Earnings Call Transcript

Thu, 16 Nov 2017 18:45:00 GMT
CQS Cayman LP Buys Biomarin Pharmaceutical Inc, Alere Inc, NetEase Inc, Sells ...

Tue, 14 Nov 2017 17:48:45 GMT
BioMarin Pharmaceutical is Now Oversold (BMRN)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

175.62

Shares Float (M)

174.24

% Held by Insiders

0.37

% Held by Institutions

99.50

Shares Short (K)

6870

Shares Short Prior Month (K)

7290

Stock Financials

EPS

-1.070

EPS Est. Current Year

-0.740

EPS Est. Next Year

-0.240

EPS Est. Next Quarter

-0.150

Forward EPS

-0.310

Book Value (p.s.)

15.950

PEG Ratio

-5.00

Profit Margin

-15.09

Operating Margin

-16.21

Return on Assets (ttm)

-3.4

Return on Equity (ttm)

-7.7

Qtrly Rev. Growth

5.8

Gross Profit (p.s.)

5.166

Sales Per Share

EBITDA (p.s.)

-0.608

Qtrly Earnings Growth

Operating Cash Flow (M)

-72.24

Levered Free Cash Flow (M)

-176.07

FoxReading.com

Valuation

P/E

-77.30

P/E Growth Ratio

P/BV

5.19

P/S

2078044416.00

P/CF

-201.07

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.